A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis
Abstract Enterovirus D68 (EV-D68) is a respiratory virus that often causes mild to moderate respiratory illnesses and, in severe cases, can lead to paralysis and rarely death, mainly in children. There is currently no vaccine or antiviral for EV-D68. Here, we report the rational design of viral 2 C...
Saved in:
| Main Authors: | Kan Li, Michael J. Rudy, Yanmei Hu, Haozhou Tan, George Lambrinidis, Xiangmeng Wu, Kyriakos Georgiou, Bin Tan, Joshua Frost, Courtney Wilson, Penny Clarke, Antonios Kolocouris, Qing-yu Zhang, Kenneth L. Tyler, Jun Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-61083-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of naturally occurring drug-resistant mutations of SARS-CoV-2 papain-like protease
by: Haozhou Tan, et al.
Published: (2025-05-01) -
EV68-228-N monoclonal antibody treatment halts progression of paralysis in a mouse model of EV-D68 induced acute flaccid myelitis
by: Michael J. Rudy, et al.
Published: (2025-04-01) -
Molecular biophysics and inhibition mechanism of influenza virus A M2 viroporin by adamantane-based drugs – Challenges in designing antiviral agents
by: Kyriakos Georgiou, et al.
Published: (2025-06-01) -
Antiviral Therapeutics Discovery for Enterovirus D68.
by: Prof Justin Jang H Chu
Published: (2025-03-01) -
Current status of enterovirus D68 worldwide and in Taiwan
by: Ya-Li Hu, et al.
Published: (2020-02-01)